Get the Stockscreener App
4.10
1.09%
-0.03
Savara Inc stock is traded at $4.10, with a volume of 306.61K.
It is down -1.09% in the last 24 hours and up +17.05% over the past month.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
See More
Previous Close:
$4.13
Open:
$4.12
24h Volume:
306.61K
Relative Volume:
0.21
Market Cap:
$707.77M
Revenue:
-
Net Income/Loss:
$-54.70M
P/E Ratio:
-12.42
EPS:
-0.33
Net Cash Flow:
$-51.36M
1W Performance:
-5.88%
1M Performance:
+17.05%
6M Performance:
+24.54%
1Y Performance:
+12.85%
1-Day Range:
$4.00
$4.20
1-Week Range:
$4.00
$4.505
52-Week Range:
$1.89
$4.505
Savara Inc Stock (SVRA) Company Profile
Name
Savara Inc
Sector
Industry
Phone
51285113796
Address
6836 BEE CAVE ROAD, AUSTIN, TX
Compare SVRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
4.095 | 831.38M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.91 | 107.10B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.46 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.79 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.16 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
187.54 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Nov-13-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-24 | Initiated | JMP Securities | Mkt Outperform |
| Nov-07-23 | Initiated | Guggenheim | Buy |
| May-16-23 | Upgrade | Jefferies | Hold → Buy |
| Mar-31-23 | Downgrade | Jefferies | Buy → Hold |
| Mar-16-21 | Initiated | Piper Sandler | Overweight |
| Mar-15-21 | Initiated | Oppenheimer | Outperform |
| Jun-13-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-13-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-13-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Aug-13-18 | Resumed | ROTH Capital | Neutral |
| Jan-03-18 | Initiated | Ladenburg Thalmann | Buy |
| Sep-27-17 | Resumed | ROTH Capital | Buy |
| Sep-22-17 | Initiated | Jefferies | Buy |
| Sep-11-17 | Initiated | JMP Securities | Mkt Outperform |
View All
Savara Inc Stock (SVRA) Latest News
Portnoy Law Firm Announces Class Action on Behalf of Savara, Inc. Investors - GlobeNewswire
Savara (SVRA) Expected to Announce Earnings on Tuesday - MarketBeat
SAVARA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently - GlobeNewswire
Burned by Savara Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Savara Inc. (SVRA) Investors of November 7, 2025 Deadline - Newsfile
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire
What Does Wall Street Think About Savara Inc. (SVRA)? - MSN
Savara Inc. stock momentum explained2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com
Short interest data insights for Savara Inc.2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com
Savara Hit with Class Action Over Molbreevi Misrepresentations - TipRanks
Latham & Watkins Advises RTW Investments in US$75 Million Royalty Funding Agreement With Savara - Legal Desire Media and Insights
Investor Alert: Deadline Approaching to Join Savara Inc. (SVRA) Class ActionContact Levi & Korsinsky - The Globe and Mail
Savara Announces Participation in Upcoming Investor Healthcare Conferences - The Joplin Globe
Savara Announces Participation in Upcoming Investor Healthcare Conferences - Benzinga
Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class ActionSVRA - Morningstar
Can Savara Inc. stock deliver surprise earnings beatJuly 2025 Trends & Real-Time Chart Breakout Alerts - newser.com
How strong dollar benefits Savara Inc. (YB4P) stockQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
Is Savara Inc. (YB4P) stock in buy zone after pullback2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
2025-11-02 | Securities Fraud Class Action Filed Against Savara Inc. (SVRA)Levi & Korsinsky Reminds Investors of November 7, 2025 | NDAQ:SVRA | Press Release - Stockhouse
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit - PR Newswire
Why Savara Inc. stock could outperform in 2025Portfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
SVRA DEADLINE: ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages Savara Inc. Investors ... - Bluefield Daily Telegraph
Class Action Filed Against Savara Inc. (SVRA) Over Securities ViolationsContact Levi & Korsinsky Today - Stockhouse
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Newsfile
Savara completes $149.5 million public offering of common stock By Investing.com - Investing.com Australia
Investors SueWallSt Over Savara Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Savara Closes $149.5 Million Public Offering - MarketScreener
Savara completes $149.5 million public offering of common stock - Investing.com
Savara (NASDAQ: SVRA) closes $149.5M offering priced at $4.20; option exercised - Stock Titan
Savara Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $149.5M - The Joplin Globe
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss ... - Bluefield Daily Telegraph
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights – SVRA - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Newsfile
Levi & Korsinsky Reminds Savara Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - Morningstar
SAVARA CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Savara Investors to ... - Bluefield Daily Telegraph
SAVARA CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
Emerald Mutual Fund Advisers Trust Grows Position in Savara Inc. $SVRA - MarketBeat
Savara Inc. $SVRA Shares Purchased by Emerald Advisers LLC - MarketBeat
Pattern recognition hints at Savara Inc. upsideJuly 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Visual analytics tools that track Savara Inc. performanceJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Chart overlay techniques for tracking Savara Inc.Market Performance Recap & Stock Timing and Entry Methods - newser.com
RTW Biotech Opportunities says Savara announces $75 million funding agreement with co - MarketScreener
Savara Announces $130 Million Public Offering - MSN
Will Savara Inc. (YB4P) stock boost dividends further2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
SVRA FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Savara Inc. Investors to ... - Caledonian Record
SVRA FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire
Applying sector rotation models to Savara Inc.Quarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Savara Inc Stock (SVRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Savara Inc Stock (SVRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McCracken Joseph S | Director |
May 29 '25 |
Buy |
2.08 |
10,000 |
20,825 |
260,837 |
| RAMSAY DAVID A | Director |
Mar 31 '25 |
Buy |
2.77 |
150,000 |
416,250 |
2,513,642 |
| Lowrance David L | Chief Financial Officer |
Dec 16 '24 |
Sale |
3.33 |
25,000 |
83,278 |
381,005 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
| Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
7.26%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):